References
- 1. Y. Liu, X. Y. Wang, X. M. Wei, Z. T. Gao and J. P. Han, Values, properties and utility of different parts of Moringa oleifera : An overview, CHM. 10 (2018) 371–378. https://doi.org/10.1016/j.chmed.2018.09.002
- 2. N. Qi, Gong. X, C. Feng, X. Wang, Y. Xu and L. Lin, Simultaneous analysis of eight vitamin E isomers in Moringa oleifera Lam. leaves by ultra performance convergence chromatography, Food Chem. 207 (2016) 157–161; https://doi.org/10.1016/j.foodchem.2016.03.089
- 3. B. Moyo, S. Oyedemi, P. J. Masika and V. Muchenje, Polyphenolic content and antioxidant properties of Moringa oleifera leaf extracts and enzymatic activity of liver from goats supplemented with Moringa oleifera leaves/sunflower seed cake, Meat Sci. 91 (2012) 441–447; https://doi.org/10.1016/j.meatsci.2012.02.029
- 4. D. Jaiswal, P. K. Rai, A. Kumar, S. Mehta and G. Watal, Effect of Moringa oleifera Lam. leaves aqueous extract therapy on hyperglycemic rats, J. Ethnopharmacol. 123 (2009) 392–396; https://doi.org/10.1016/j.jep.2009.03.036
- 5. P. Chumark, P. Khunawat, Y. Sanvarinda, S. Phornchirasilp, N. P. Morales, L. Phivthong-ngam, P. Ratanachamnong, S. Srisawat and K. S. Pongrapeeporn, The in vitro and ex vivo antioxidant properties, hypolipidaemic and antiatherosclerotic activities of water extract of Moringa oleifera Lam. Leaves, J. Ethnopharmacol. 116 (2008) 439–446; https://doi.org/10.1016/j.jep.2007.12.010
- 6. S. Charoensin, Antioxidant and anticancer activities of Moringa oleifera leaves, J. Med. Plants Res. 8 (2014) 318–325; https://doi.org/10.5897/JMPR2013.5353
- 7. L. L. Jung, Soluble extract from Moringa oleifera leaves with a new anticancer activity, Plos One 9 (2014) e95492; https://doi.org/10.1371/journal.pone.0095492
- 8. S. Sreelatha, A. Jeyachitra and P. R. Padma, Antiproliferation and induction of apoptosis by Moringa oleifera leaf extract on human cancer cells, Food Chem. Toxicol. 49 (2011) 1270–1275; https://doi.org/10.1016/j.fct.2011.03.006
- 9. PubChem Identifier: CID 5280863; https://pubchem.ncbi.nlm.nih.gov/compound/5280863; access date February 26, 2019.
- 10. A. Barve, C. Chen, V. Hebbar, J. Desiderio, C. L. L. Saw and A. N. Kong, Metabolism, oral bioavail-ability and pharmacokinetics of chemopreventive kaempferol in rats, Biopharm. Drug Dispos. 30 (2009) 356–365; https://doi.org/10.1002/bdd.677
- 11. L. Gao, G. Liu, X. Wang, F. Liu, Y. Xu and J. Ma, Preparation of a chemically stable quercetin formulation using nanosuspension technology, Int. J. Pharm. 404 (2011) 231–237; https://doi.org/10.1016/j.ijpharm.2010.11.009
- 12. K. A. Khaled, Y. M. El-Sayed and B. M. Al-Hadiya, Disposition of the flavonoid quercetin in rats after single intravenous and oral doses, Drug Dev. Ind. Pharm. 29 (2003) 397–403; https://doi.org/10.1081/DDC-120018375
- 13. R. Gugler, M. Leschik and H. J. Dengler, Disposition of quercetin in man after single oral and intravenous doses, Eur. J. Clin. Pharmacol. 9 (1975) 229–234.
- 14. K. Zhang, L. Gu, J. Chen, Y. Zhang, Y. Jiang, L. Zhao, K. Bi and X. Chen, Preparation and evaluation of kaempferol-phospholipid complex for pharmacokinetics and bioavailability in SD rats, J. Pharm. Biomed. Anal. 114 (2015) 168–175; https://doi.org/10.1016/j.jpba.2015.05.017
- 15. K. Zhang, M. Zhang, Z. Liu, Y. Zhang, L. Gu, G. Hu, X. Chen and J. Jia, Development of quercetinphospholipid complex to improve the bioavailability and protection effects against carbon tetrachloride-induced hepatotoxicity in SD rats, Fitoterapia 113 (2016) 102–109; https://doi.org10.1016/j.fitote.2016.07.008
- 16. R. Pangeni, S. W. Kang, M. Oak, E. Y. Park and J. W. Park, Oral delivery of quercetin in oil-in-water nanoemulsion: In vitro characterization and in vivo anti-obesity efficacy in mice, J. Funct. Foods 38 (2017) 571–581; https://doi.org/10.1016/j.jff.2017.09.059
- 17. K. AboulFotouh, A. A. Allam, M. El-Badry and A. M. El-Sayed, Role of self-emulsifying drug delivery systems in optimizing the oral delivery of hydrophilic macromolecules and reducing interindividual variability, Colloids Surf. B Biointerfaces 167 (2018) 82–92; https://doi.org/10.1016/j.colsurfb.2018.03.034
- 18. R. N. Gursoy and S. Benita, Self-emulsifying drug delivery systems (SEDDS) for improved oral bioavailability of lipophilic drugs, Biomed. Pharmacother. 58 (2004) 173–182; https://doi.org/10.1016/j.biopha.2004.02.001
- 19. S. Setthacheewakul, S. Mahattanadul, N. Phadoongsombut, W. Pichayakorn and R. Wiwattanapatapee, Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats, Eur. J. Pharm. Biopharm. 76 (2010) 475–485; https://doi.org/10.1016/j.ejpb.2010.07.011
- 20. A. K. Nayak and P. P. Panigrahi, Solubility enhancement of etoricoxib by cosolvency approach, ISRN. 2012 (2012) 1–5, http://dx.doi.org/10.5402/2012/820653
- 21. M. M. Bandivadeka, S. S. Pancholi, R. Kaul-Ghanekar, A. Choudhari and S. Koppikar, Self-micro-emulsifying smaller molecular volume oil (Capmul MCM) using non-ionic surfactants: a delivery system for poorly water-soluble drug, Drug Dev. Ind. Pharm. 38 (2012) 883–892, https://doi.org/10.3109/03639045.2011.631548
- 22. M. A. Abd Sisak, R. Daik and S. Ramli, Study on the effect of oil phase and co-surfactant on microemulsion systems, MJAS 21 (2017) 1409–1416; https://doi.org/10.17576/mjas-2017-2106-23